- Home
- Research
- Mental Health
- More Pregnant and Breastfeeding Women Are Using Cannabis.
More Pregnant and Breastfeeding Women Are Using Cannabis.
AI Summary
Recent research shows that more pregnant and breastfeeding women are using cannabis, often because they believe it's safe. This trend is concerning because scientific evidence suggests cannabis use during pregnancy and lactation may be associated with negative effects on fetal and infant development. The study highlights a dangerous disconnect between public perception and scientific evidenceβmany women may feel comfortable using cannabis during these critical periods based on the idea that "it's natural" or "less harmful than other substances," when in fact the research suggests otherwise.
The researchers examined patterns of cannabis use among pregnant and breastfeeding women and reviewed available evidence on potential health risks. They found that increasing numbers of women are using cannabis during pregnancy and while nursing, often influenced by the belief that cannabis is a safer alternative to pharmaceutical treatments or that it carries minimal risk. However, the available research links prenatal cannabis exposure to potential adverse birth outcomes, including altered fetal development and concerns about infant health through breast milk exposure.
The practical implication is clear: pregnant and breastfeeding women should be informed about the potential risks associated with cannabis use during these sensitive periods. Healthcare providers need to educate patients about the gap between perceived safety and actual scientific evidence, ensuring that women making decisions about cannabis use have accurate information about potential impacts on their babies' development and health.
π‘ Key Findings
π
Original Abstract
Related Research
Similar Studies
More Mental Health research papers you might find interesting.
Review describes AHC and reports cannabidiol as an additional treatment option
Review finds school prevention often covers cannabis, but evidence gaps remain
Antipsychotics eased symptoms, but relapse-prevention evidence remains thin
Explore More Research
Stay informed about the latest cannabis science.